Literature DB >> 18977985

Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries.

Ulrich Seybold1, J Sue Halvosa, Nancy White, Victoria Voris, Susan M Ray, Henry M Blumberg.   

Abstract

OBJECTIVE: The goal of this study was to define more clearly the impact of community-acquired methicillin-resistant Staphylococcus aureus clones (eg, USA300 and USA400) on colonization and infection in infants in intensive care nurseries and potential modes of transmission of community-acquired methicillin-resistant S aureus clones.
METHODS: Prospective surveillance for methicillin-resistant S aureus colonization and infection was performed among infants in the intensive care nurseries at Grady Memorial Hospital (Atlanta, GA) between 1993 and 2006. Beginning in September 2004, nares surveillance cultures were collected at admission. Methicillin-resistant S aureus isolates were genotyped by using pulsed-field gel electrophoresis and multiplex polymerase chain reaction assays for staphylococcal chromosomal cassette mec gene complex type and Panton-Valentine leukocidin genes. Prevalence of and risk factors for colonization with community-acquired versus health care-associated methicillin-resistant S aureus clones (eg, USA100) were assessed.
RESULTS: Between 1993 and 2006, 130 (3.5%) of 3707 infants were identified to be colonized with methicillin-resistant S aureus. Twelve (1.2%) of 996 admission nares cultures were positive for methicillin-resistant S aureus (since initiation of admission cultures in September 2004). Community-acquired methicillin-resistant S aureus clones were first recovered in 1998; the proportion of methicillin-resistant S aureus clones of community origin increased significantly between 1998 and 2004. Multivariate analysis identified vaginal delivery and maternal smoking, both among infants of mothers receiving systemic antibiotic treatment before delivery, as independent predictors for neonatal colonization with community-acquired methicillin-resistant S aureus. Systemic antibiotic therapy before delivery for nonsmoking mothers delivering through cesarean section and possibly endotracheal intubation were associated with the recovery of health care-associated methicillin-resistant S aureus clones.
CONCLUSIONS: Community-acquired methicillin-resistant S aureus clones have emerged as a major cause of methicillin-resistant S aureus colonization in high-risk newborns. Community-acquired methicillin-resistant S aureus recovery was associated with acquisition during birth, whereas health care-associated methicillin-resistant S aureus clones seemed to be transmitted nosocomially.

Entities:  

Mesh:

Year:  2008        PMID: 18977985     DOI: 10.1542/peds.2007-3161

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

1.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among patients admitted to adult intensive care units: the STAR*ICU trial.

Authors:  Nisha Nair; Ekaterina Kourbatova; Katharine Poole; Charmaine M Huckabee; Patrick Murray; W Charles Huskins; Henry M Blumberg
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-20       Impact factor: 3.254

2.  Trends in methicillin-resistant Staphylococcus aureus anovaginal colonization in pregnant women in 2005 versus 2009.

Authors:  Karina A Top; Richard C Huard; Zachary Fox; Fann Wu; Susan Whittier; Phyllis Della-Latta; Lisa Saiman; Adam J Ratner
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

3.  Impact of neonatal intensive care bed configuration on rates of late-onset bacterial sepsis and methicillin-resistant Staphylococcus aureus colonization.

Authors:  Samuel Julian; Carey-Ann D Burnham; Patricia Sellenriek; William D Shannon; Aaron Hamvas; Phillip I Tarr; Barbara B Warner
Journal:  Infect Control Hosp Epidemiol       Date:  2015-06-25       Impact factor: 3.254

4.  Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit.

Authors:  Alison J Carey; Phyllis Della-Latta; Richard Huard; Fann Wu; Phillip L Graham; Diane Carp; Lisa Saiman
Journal:  Infect Control Hosp Epidemiol       Date:  2010-06       Impact factor: 3.254

5.  Infant Colonization With Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococci Preceding Neonatal Intensive Care Unit Discharge.

Authors:  Sarah A Clock; Haomiao Jia; Sameer Patel; Yu-Hui Ferng; Luis Alba; Susan Whittier; Patricia DeLaMora; Setareh Tabibi; Jeffrey Perlman; David Paul; Theoklis Zaoutis; Elaine Larson; Lisa Saiman
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

6.  Predictors of Staphylococcus aureus Rectovaginal Colonization in Pregnant Women and Risk for Maternal and Neonatal Infections.

Authors:  Karina A Top; Amanda Buet; Susan Whittier; Adam J Ratner; Lisa Saiman
Journal:  J Pediatric Infect Dis Soc       Date:  2012-03-01       Impact factor: 3.164

7.  Emergence of community-associated methicillin-resistant Staphylococcus aureus strains in the neonatal intensive care unit: an infection prevention and patient safety challenge.

Authors:  P J Reich; M G Boyle; P G Hogan; A J Johnson; M A Wallace; A M Elward; B B Warner; C-A D Burnham; S A Fritz
Journal:  Clin Microbiol Infect       Date:  2016-04-25       Impact factor: 8.067

8.  Executive summary of the workshop on infection in the high-risk infant.

Authors:  R D Higgins; C J Baker; T N K Raju
Journal:  J Perinatol       Date:  2010-01-14       Impact factor: 2.521

9.  Tobacco Smoking as a Risk Factor for Increased Antibiotic Prescription.

Authors:  Michael B Steinberg; Ayse Akincigil; Eun Jung Kim; Rory Shallis; Cristine D Delnevo
Journal:  Am J Prev Med       Date:  2015-12-15       Impact factor: 5.043

Review 10.  Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit.

Authors:  Melissa U Nelson; Patrick G Gallagher
Journal:  Semin Perinatol       Date:  2012-12       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.